Arunjyothi Bio Ventures Intrinsic Value
Arunjyothi Bio Ventures intrinsic value. Arunjyothi Bio Ventures (ABVL) median intrinsic value is ₹9.80 from 2 valuation models (range ₹10–₹10), vs current price ₹3.92 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. For current market price and key ratios, visit ABVL stock price BSE.
ABVL Valuation Methods Summary — DCF, Graham Number & P/E
Arunjyothi Bio Ventures intrinsic value across 2 models vs current price ₹3.92 — upside/downside and value range per method. Compare with Arunjyothi Bio Ventures valuation methods to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹9.80 | ₹8.82 - ₹10.78 | +150.0% | Book Value/Share: ₹15.26, P/B: 0.8x |
| Simple DCF (5Y) | dcf | ₹9.80 | ₹7.84 - ₹11.76 | +150.0% | CF Growth: 15.0%, Discount: 15% |
ABVL Intrinsic Value vs Market Price — All Valuation Models
Arunjyothi Bio Ventures fair value range ₹10–₹10 vs current market price ₹3.92 across 2 valuation models. Read ABVL dividend track record for the complete payout history and dividend yield track record.
ABVL Intrinsic Value Analysis — Undervalued or Overvalued?
Arunjyothi Bio Ventures median intrinsic value ₹9.80, current price ₹3.92 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of ABVL?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Arunjyothi Bio Ventures (ABVL) is ₹9.80 (median value). With the current market price of ₹3.92, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹9.80 to ₹9.80, indicating ₹9.80 - ₹9.80.
Is ABVL undervalued or overvalued?
Based on our multi-method analysis, Arunjyothi Bio Ventures (ABVL) appears to be trading below calculated value by approximately 150.0%.
ABVL Financial Health — Key Ratios vs Industry Benchmarks
Arunjyothi Bio Ventures financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.50 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Operating Margin | 38.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
ABVL Cash Flow Quality — Operating & Free Cash Flow
Arunjyothi Bio Ventures operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹10 Cr | ₹8 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹2 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2024 | ₹6 Cr | ₹-6 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹-13 Cr | ₹-23 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |